Literature DB >> 18320956

Challenging stereotyping and bias: a voice simulation study.

Karen S Dearing1, Sheryl Steadman.   

Abstract

Stigma is a barrier to mental health care access for patients with schizophrenia and can interfere with developing therapeutic relationships. This study demonstrates success of a voice simulation experience during orientation in changing the biases of nursing students and the effect on the development of the nurse-patient relationship. Ninety-four individuals participated; 52 received a voice simulation experience during orientation, and 42 received orientation with no voice simulation experience. The Medical Condition Regard Scale was administered before and after orientation. Posttest paired t test results show significant differences in attitudes toward patients with voice hearing experiences between the two groups. The themes of personal growth from the focus groups postorientation include Affective Experience, Physical Experience, and Empathy. Findings demonstrate that the orientation process should include methods to challenge stereotyping and bias to decrease stigma, improve service access, and enhance the ability to develop therapeutic relationships.

Entities:  

Mesh:

Year:  2008        PMID: 18320956     DOI: 10.3928/01484834-20080201-07

Source DB:  PubMed          Journal:  J Nurs Educ        ISSN: 0148-4834            Impact factor:   1.726


  2 in total

1.  Use of an Auditory Hallucination Simulation to Increase Student Pharmacist Empathy for Patients with Mental Illness.

Authors:  Elizabeth T Skoy; Heidi N Eukel; Jeanne E Frenzel; Amy Werremeyer; Becky McDaniel
Journal:  Am J Pharm Educ       Date:  2016-10-25       Impact factor: 2.047

2.  Attitudes of undergraduate health science students towards patients with intellectual disability, substance abuse, and acute mental illness: a cross-sectional study.

Authors:  Malcolm J Boyle; Brett Williams; Ted Brown; Andrew Molloy; Lisa McKenna; Elizabeth Molloy; Belinda Lewis
Journal:  BMC Med Educ       Date:  2010-10-21       Impact factor: 2.463

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.